Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab in Elderly KRAS WT Advanced CRC
NCT01522612Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Apr 2013
- Primary completion
- Jan 2015
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of KL-140 in metastatic colorectal cancer (mCRC), sponsored by European Organisation for Research and Treatment of Cancer. Started Apr 2013; status: terminated.
02
Drugs
KL-140
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01522612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01522612.